At baseline | At the end of treatment | P value | |
---|---|---|---|
Hemoglobin (gm/dl) | 12.22 ± 1.6 | 11.25 ± 1.5 | P < 0.001 |
WBCs × 103/ml | 4.63 ± 1.5 | 4.63 ± 1.7 | P = 1.0 |
Platelet count × 103/ml | 92.5 (50.0–356) | 105 (37.0–392) | P = 0.26 |
ALT/ULN (folds) | 1.255 (0.22–5.35) | 0.67 (0.2–2.0) | P < 0.001 |
AST/ULN (folds) | 1.75 (0.4–5.85) | 0.9 (0.25–7.0) | P < 0.001 |
Serum albumin (gm/dl) | 2.85 ± 0.4 | 3.23 ± 0.5 | P < 0.001 |
Serum bilirubin (mg/dl) | 1.37 (0.3–3.2) | 1.2 (0.2–3.4) | P = 0.019 |
I.N.R. | 1.33 ± 0.24 | 1.38 ± 0.24 | P = 0.16 |
Serum creatinine (mg/dl) | 0.84 ± 0.2 | 0.89 ± 0.3 | P = 0.08 |
AFP (IU/l) | 10.8 (0.1–201) | 5.8 (0.2–24) | P < 0.001 |